Medigrowth Trading Australia

Medigrowth is an Australian medicinal cannabis company dedicated to the research, development, and commercialization of cannabinoid-based therapies. Founded in 2017 and headquartered in Geelong, the company focuses on providing high-quality, pharmaceutical-grade cannabis products to patients with unmet medical needs. Medigrowth maintains a strong emphasis on clinical evidence, partnering with institutions like Deakin University to explore treatments for conditions such as cancer and chronic pain. Their operations span the medicinal cannabis value chain, including cultivation, extraction, and distribution under the Australian regulatory framework. The company utilizes a patient-centric approach, offering a range of oils and flower products through the Special Access Scheme and Authorized Prescriber pathways. Medigrowth is also active in the AgTech space, focusing on plant genetics and optimized cultivation techniques to ensure product consistency and potency.